NCT04644965

Brief Summary

The two most common congenital abdominal wall defects (AWD) are gastroschisis and omphalocele. Prenatal detection is often possible and the defects are differentiated by the presence or absence of a sac around the eviscerated organs. A omphalocele occurs in 0.6-4.8 in 10,000 live births compared to 4.5 in 10,000 live births with gastroschisis. In the last years a rising incidence of gastroschisis has been shown worldwide. Both forms of AWDs necessitate early surgical intervention, mostly in one or two stages, and support at an intensive care unit in the first days of life. Additionally, patients need parenteral feeding in the first weeks of life. The outcome depends on the size of the defect and on the associated malformations. The literature about long-term outcome of these malformations is scarce. Some publications have reported long-term complications like redo-surgical procedures because of fascial gaps or umbilical or incisional hernias. Furthermore, stool irregularities, abdominal pain and several admission to the hospital due to ileus or sub-ileus have been described. Additionally, half of the patients are unsatisfied with the cosmetic result. Some other studies have shown that children born with an AWD have the same quality of life (QoL) compared with the healthy community. Nevertheless, patients with AWDs need a standardized, structured and multimodal long-time follow-up program to be able to detect any problems early and give advice to understand their illness in order to achieve the same QoL as healthy children. Therefore, the aim of this dissertation will be:

  • to prospectively assess the motor activity, cardiopulmonary performance capacity and QoL of patients treated with AWDs in our Department
  • to suggest a new standardized follow-up protocol for patients born with an AWD

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2020

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 5, 2020

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 19, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 25, 2020

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2021

Completed
2.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 31, 2023

Completed
Last Updated

October 5, 2023

Status Verified

January 1, 2023

Enrollment Period

5 months

First QC Date

November 19, 2020

Last Update Submit

October 4, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • Motor Activity

    Comparison of the Dordel Koch Test between the two groups. (T-Test or Mann-Withney-U)

    30 minutes

  • Cardiopulmonary Performance Capacity - lung function

    Comparing relative lung function \[%\] between the two groups.(T-Test or Mann-Withney-U)

    30 minutes

  • Cardiopulmonary Performance Capacity - peak VO2

    Comparing peak VO2 between the two groups.(T-Test or Mann-Withney-U)

    30 minutes

  • Gastrointestinal Quality of Life

    Gastrointestinal Quality of Life Index (GIQLI): most desirable option: 4 points, least desirable option: 0 points GIQLI score: sum of the points - Score Range: 0-148 Compare the mean between the two groups (T-Test or Mann-Withney-U)

    15 minutes

Study Arms (2)

Abdominal Wall Defect

patients born with an abdominal wall defect

Diagnostic Test: CombynTM Function & Spaces ECGDiagnostic Test: Blood TakingDiagnostic Test: SpiroergometryDiagnostic Test: Dordel Koch Test (DKT)Diagnostic Test: UltrasoundDiagnostic Test: Stance and gait analyses

Control Group

age and sex matched Control Group

Diagnostic Test: CombynTM Function & Spaces ECGDiagnostic Test: Blood TakingDiagnostic Test: SpiroergometryDiagnostic Test: Dordel Koch Test (DKT)Diagnostic Test: UltrasoundDiagnostic Test: Stance and gait analyses

Interventions

Multi-frequency impedance measurement to assess the muscle and fat mass

Abdominal Wall DefectControl Group
Blood TakingDIAGNOSTIC_TEST

Sampling of blood of the finger pad to assess liver function

Abdominal Wall DefectControl Group
SpiroergometryDIAGNOSTIC_TEST

Spiroergometry to assess cardiopulmonary capacity. The intensity will be raised in steps until total exhaustion. In between each step we will take blood of the ear lobe to determine the lactate level

Abdominal Wall DefectControl Group
Dordel Koch Test (DKT)DIAGNOSTIC_TEST

Dordel Koch Test (DKT) to evaluate the motor activity. The DKT is a heterogeneous test battery for children and adolescents and consists of seven parts: lateral jumping, sit and reach, situps, long stand jump, one-legged stand, push-ups and 6-min-run

Abdominal Wall DefectControl Group
UltrasoundDIAGNOSTIC_TEST

Ultrasound for abdominal wall muscles

Abdominal Wall DefectControl Group

Stance and gait analyses for measuring the core stability

Abdominal Wall DefectControl Group

Eligibility Criteria

Age6 Years - 18 Years
Sexall
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

All patients born with an abdominal wall defect between 6-18years old are invited personally for examinations.

You may qualify if:

  • All patients born with an abdominal wall defect

You may not qualify if:

  • mental disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Medical University of Graz

Graz, Styria, 8036, Austria

Location

Related Publications (4)

  • Frybova B, Kokesova A, Zemkova D, Mixa V, Vlk R, Rygl M. Quality of life in patients with gastroschisis is comparable with the general population: A questionnaire survey. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017 Mar;161(1):75-79. doi: 10.5507/bp.2016.059. Epub 2016 Dec 13.

    PMID: 27982137BACKGROUND
  • Snoep MC, de Heus R, Manten GTR, Lap CCMM, Snoeker BAM, Lindeboom MYA. Gastro-intestinal function and quality of life are favorable in adolescent and adult gastroschisis patients. Early Hum Dev. 2020 Feb;141:104936. doi: 10.1016/j.earlhumdev.2019.104936. Epub 2019 Dec 23.

    PMID: 31874371BACKGROUND
  • Harris EL, Minutillo C, Hart S, Warner TM, Ravikumara M, Nathan EA, Dickinson JE. The long term physical consequences of gastroschisis. J Pediatr Surg. 2014 Oct;49(10):1466-70. doi: 10.1016/j.jpedsurg.2014.03.008.

    PMID: 25280647BACKGROUND
  • Kaiser MM, Kahl F, von Schwabe C, Halsband H. [Omphalocele and gastroschisis. Outcome--complications--follow-up--quality of life]. Chirurg. 2000 Oct;71(10):1256-62. doi: 10.1007/s001040051212. German.

    PMID: 11077588BACKGROUND

MeSH Terms

Interventions

UltrasonographyGait Analysis

Intervention Hierarchy (Ancestors)

Diagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisGaitPhysical ExaminationPhysical Functional PerformancePhysical FitnessHealthPopulation Characteristics

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2020

First Posted

November 25, 2020

Study Start

October 5, 2020

Primary Completion

February 28, 2021

Study Completion

May 31, 2023

Last Updated

October 5, 2023

Record last verified: 2023-01

Locations